Critical study angers maker of disputed AIDS treatment

Associated Press

CHICAGO — A study suggesting that a vaccine-like AIDS treatment is ineffective has erupted into a public dispute between the manufacturer that paid for much of the study and doctors who say the company tried to squelch their research.

The study’s conclusions, published in today’s Journal of the American Medical Association, echo doubts about HIV-1 Immunogen expressed several years ago by advisers to the Food and Drug Administration.

The results suggest that when added to the drug regimen for HIV-infected patients, HIV-1 Immunogen failed to reduce the risk of developing full-blown AIDS. The drug carries the brand name Remune.

Immune Response Corp., the drug’s manufacturer, contends researchers omitted favorable data and skewed the results.

The company entered a fairly common arbitration process during which it tried to produce "a more balanced manuscript," said Dr. Ronald Moss, the company’s vice president of medical and scientific affairs.

Instead, the researchers violated their contractual agreement and published incomplete findings, Moss said.

"It seems like tabloid journalism that JAMA would not investigate this further" before publishing, Moss said.

HIV-1 Immunogen was developed by the late Dr. Jonas Salk, who created the first polio vaccine. It was developed before powerful "drug cocktails" including protease inhibitors became standard HIV treatment, and Immune Response says subjects’ use of such drugs affected the findings in the JAMA study.

Dr. James Kahn of the University of California at San Francisco, the study’s lead author, said the company withheld important data and then tried to suppress publication.

The company denies both claims. In an arbitration complaint last month, Immune Response also demanded $7 million to $10 million from Kahn and the university, claiming dissemination of the negative findings caused it financial harm, UCSF attorney Christopher Patti said.

The study of 2,527 patients nationwide found that Remune did boost levels of infection-fighting white blood cells, but the authors questioned whether the effect was clinically significant.

The university contends Kahn was allowed to publish the results.

JAMA editor Dr. Catherine DeAngelis defended the journal’s decision to publish the study. "This study stands on its own scientific merit," she said. "It was peer-reviewed as such."

In a JAMA editorial, she said the dispute illustrates what can happen when disagreement erupts between researchers and a funding sponsor who "has a proprietary interest in the findings."

Copyright ©2000 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Talk to us

More in Local News

Mel Jennings sits in his structure during a point-in-time count of people facing homelessness in Everett, Washington on Tuesday, Jan. 24, 2023. Mel has had a brain and spinal surgery, and currently has been homeless for a year. (Annie Barker / The Herald)
Annual homeless count aims to give snapshot of housing crisis

Volunteers set out into the rain Tuesday to count all the people facing homelessness in central Everett.

Catherine Berwicks loads ballots into a tray after scanning them at the Snohomish County Elections Ballot Processing Center on Tuesday, Aug. 4, 2020 in Everett, Wa.  (Andy Bronson / The Herald)
Lawmakers push to boost voting in county jails across the state

A House bill envisions an approach similar to what’s been happening in the Snohomish County Jail for several years.

Vandalism at Seaview Park on Jan. 21, 2023 in Edmonds, Washington. (Edmonds Police Department)
Police seek suspects in repeated vandalism at Edmonds parks

Vandals have done over $10,000 of damage to parks across the city, including suspected arson and graffiti with hate speech.

One worker looks up from the cargo area as another works in what will be the passenger compartment on one of the first Boeing 787 jets as it stands near completion at the front of the assembly line, Monday, May 19, 2008, in Everett, Wash. The plane, the first new Boeing jet in 14 years, is targeted for power on in June followed by an anticipated first flight sometime late in 2008.  (AP Photo/Elaine Thompson)
Boeing workers long-exposed to carcinogen far above legal limits

The company confirmed in depositions that parts of its Everett plant still don’t meet 2010 standards.

CarlaRae Arneson, of Lynnwood, grabs a tea press full of fresh tea from Peanut the server robot while dining with her 12-year-old son Levi at Sushi Hana on Thursday, Jan. 5, 2023, in Lynnwood, Washington. CarlaRae said she and her son used to visit the previous restaurant at Sushi Hana’s location and were excited to try the new business’s food. (Ryan Berry / The Herald)
Peanut the robot waitress is on a roll at Lynnwood’s Sushi Hana

She’s less RoboCop and more Rosey as she patrols the restaurant, making sure everyone has a drink and good time.

Traffic moves along Highway 526 in front of Boeing’s Everett Production Facility on Nov. 28, 2022, in Everett, Washington. (Olivia Vanni / Sound Publishing)
Boeing settles with Everett security guard claiming chemical exposure

Holly Hawthorne was assigned to Building 45-335 at the south end of Paine Field, while employees used aerosolized chemical sprays nearby.

A section of contaminated Wicks tidelands on Thursday, Jan. 19, 2023 in Everett, Washington. (Olivia Vanni / The Herald)
Port acquisition marks next step in toxic cleanup on Everett waterfront

Private owners donated land near the contaminated Wicks Tide Flats to the Port of Everett. Cleanup work could begin within the year.

FILE - In this photo taken Oct. 2, 2018, semi-automatic rifles fill a wall at a gun shop in Lynnwood, Wash. Gov. Jay Inslee is joining state Attorney General Bob Ferguson to propose limits to magazine capacity and a ban on the sale of assault weapons. (AP Photo/Elaine Thompson, File)
Democrats advance assault weapons ban, new rules for gun buyers

The measures passed a House committee without Republican support. They are part of a broader agenda to curb gun violence.

U.S. Attorney Nick Brown and the victim of a brutal attack in 2018 answer questions from reporters on Jan. 27, 2023 in Seattle, Washington. (Jake Goldstein-Street / The Herald)
White supremacists sentenced for racist beating at Lynnwood bar

A federal judge handed out stiffer sentences than prosecutors had asked for in a series of sentencing hearings Friday.

Most Read